{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T23:04:21Z","timestamp":1782947061662,"version":"3.54.5"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010566","name":"Consejer\u00eda de Salud, Junta de Andaluc\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010566","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.ejmech.2019.111840","type":"journal-article","created":{"date-parts":[[2019,11,3]],"date-time":"2019-11-03T13:21:51Z","timestamp":1572787311000},"page":"111840","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Optimization of piperazine-derived ureas privileged structures for effective antiadenovirus agents"],"prefix":"10.1016","volume":"185","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0029-7003","authenticated-orcid":false,"given":"Sarah","family":"Mazzotta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Antonio","family":"Marrugal-Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Vega-Holm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Serna-Gallego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"\u00c1lvarez-Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Berastegui-Cabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"P\u00e9rez del Palacio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caridad","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6846-5582","authenticated-orcid":false,"given":"Francesca","family":"Aiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jer\u00f3nimo","family":"Pach\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Iglesias-Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Manuel","family":"Vega-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"S\u00e1nchez-C\u00e9spedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.111840_bib1","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/srep01812","article-title":"Molecular evolution of human adenoviruses","volume":"3","author":"Robinson","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2019.111840_bib2","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1128\/CMR.00052-07","article-title":"Adenoviruses in immunocompromised hosts","volume":"21","author":"Echavarria","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2019.111840_bib3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1128\/CMR.00116-13","article-title":"Adenovirus infections in immunocompetent and immunocompromised patients","volume":"27","author":"Lion","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2019.111840_bib4","first-page":"e401","article-title":"Gastroenteritis in childhood: a retrospective study of 650 hospitalized pediatric patients","volume":"15","author":"Wiegering","year":"2011","journal-title":"Int. J. Infect. Dis.: IJID: Off. Publ. Int. Soc. Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.111840_bib5","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/jmv.21136","article-title":"Detection of a broad range of human adenoviruses in respiratory tract samples using a sensitive multiplex real-time PCR assay","volume":"80","author":"Wong","year":"2008","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.ejmech.2019.111840_bib6","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1111\/j.1600-6143.2005.01033.x","article-title":"A\u00a0surveillance study of adenovirus infection in adult solid organ transplant recipients","volume":"5","author":"Humar","year":"2005","journal-title":"Am. J. Transplant.: Off. J. Am. Soc. Transplant. Am. Soc. Transplant Surg."},{"issue":"Suppl 4","key":"10.1016\/j.ejmech.2019.111840_bib7","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1111\/j.1600-6143.2009.02907.x","article-title":"Practice and AST Infectious Diseases Community of Practice, Adenovirus in solid organ transplant recipients","volume":"9","author":"Ison","year":"2009","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.ejmech.2019.111840_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171687","article-title":"Etiology of severe pneumonia in Ecuadorian children","volume":"12","author":"Jonnalagadda","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2019.111840_bib9","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3201\/eid2204.151403","article-title":"Severe infections with human adenovirus 7d in 2 adults in family, Illinois, USA","volume":"22","author":"Kajon","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.111840_bib10a","doi-asserted-by":"crossref","first-page":"848","DOI":"10.21037\/jtd.2016.03.38","article-title":"Severe adenovirus community-acquired pneumonia in immunocompetent adults: chest radiographic and CT findings","volume":"8","author":"Tan","year":"2016","journal-title":"J.\u00a0Thorac. Dis."},{"key":"10.1016\/j.ejmech.2019.111840_bib10b","article-title":"Severe community-acquired pneumonia caused by human adenovirus in immunocompetent adults: a multicenter case series","volume":"11","author":"Tan","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2019.111840_bib11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13104-016-2370-2","article-title":"Severe community-acquired adenovirus pneumonia treated with oral ribavirin: a case report","volume":"10","author":"Yoon","year":"2017","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.ejmech.2019.111840_bib12","first-page":"19051","article-title":"Clinical data analysis of 19 cases of community-acquired adenovirus pneumonia in immunocompetent adults","volume":"8","author":"Yu","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.ejmech.2019.111840_bib13","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/rmv.589","article-title":"Clinical features and treatment of adenovirus infections","volume":"18","author":"Lenaerts","year":"2008","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.ejmech.2019.111840_bib14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.antiviral.2014.05.010","article-title":"Inhibition of adenovirus replication by a trisubstituted piperazin-2-one derivative","volume":"108","author":"Sanchez-Cespedes","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2019.111840_bib15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jcv.2010.10.016","article-title":"Eradication of disseminated adenovirus infection in a pediatric hematopoietic stem cell transplantation recipient using the novel antiviral agent CMX001","volume":"50","author":"Paolino","year":"2011","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.ejmech.2019.111840_bib16","doi-asserted-by":"crossref","first-page":"7293","DOI":"10.1073\/pnas.0800200105","article-title":"CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal model","volume":"105","author":"Toth","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2019.111840_bib17","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.antiviral.2018.08.004","article-title":"Inhibition of adenovirus serotype 14 infection by octadecyloxyethyl esters of (S)-[(3-hydroxy-2-phosphonomethoxy)propyl]- nucleosides in\u00a0vitro","volume":"158","author":"Kumakia","year":"2018","journal-title":"Antivir. Res."},{"issue":"2","key":"10.1016\/j.ejmech.2019.111840_bib18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.32607\/20758251-2018-10-2-58-64","article-title":"1-(4-Phenoxybenzyl) 5-aminouracil derivatives and their analogues \u2013 novel inhibitors of human adenovirus replication","volume":"10","author":"Nikitenko","year":"2018","journal-title":"Acta Naturae"},{"key":"10.1016\/j.ejmech.2019.111840_bib19","doi-asserted-by":"crossref","first-page":"5182","DOI":"10.1016\/j.bmcl.2016.09.071","article-title":"First discovery of novel 3-hydroxy-quinazoline-2,4(1H,3H)-diones as specific anti-vaccinia and adenovirus agents via \u2018privileged scaffold\u2019 refining approach","volume":"26","author":"Kang","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111840_bib20a","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ejmech.2012.10.042","article-title":"Isoprenyl-thiourea and urea derivatives as new farnesyl diphosphate analogues: synthesis and in\u00a0vitro antimicrobial and cytotoxic activities","volume":"58","author":"Vega-P\u00e9rez","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111840_bib20b","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ejmech.2013.10.020","article-title":"Aziridines from alkenyl-b-D-galactopyranoside derivatives: stereoselective synthesis and in\u00a0vitro selective anticancer activity","volume":"70","author":"Vega-P\u00e9rez","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111840_bib20c","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/ddr.21483","article-title":"Selective cytotoxic activity and DNA damage by an epoxyalkyl galactopyranoside","volume":"79","author":"Burgos-Mor\u00f3n","year":"2018","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejmech.2019.111840_bib21","doi-asserted-by":"crossref","first-page":"5432","DOI":"10.1021\/acs.jmedchem.6b00300","article-title":"New 4-Acyl-1-phenylaminocarbonyl-2-phenylpiperazine derivatives as potential inhibitors of adenovirus infection. Synthesis, biological evaluation, and structure activity relationships","volume":"59","author":"S\u00e1nchez-C\u00e9spedes","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111840_bib22a","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2174\/1386207317666140122101631","article-title":"Old friends in new guise\": exploiting privileged structures for scaffold Re-Evolution\/Refining","volume":"17","author":"Song","year":"2014","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"10.1016\/j.ejmech.2019.111840_bib22b","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1016\/j.bmcl.2010.06.038","article-title":"Optimization of privileged structures for selective and potent melanocortin subtype-4 receptor ligands","volume":"20","author":"Hong","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111840_bib23","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/135965350501000204","article-title":"In\u00a0vitro susceptibility of adenovirus to antiviral drugs is species-dependent","volume":"10","author":"Morfin","year":"2005","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.ejmech.2019.111840_bib24","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1086\/498151","article-title":"Clinical and in\u00a0vitro evaluation of cidofovir for treatment of adenovirus infection in pediatric hematopoietic stem cell transplant recipients","volume":"41","author":"Muller","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.111840_bib25","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1089\/104303403765255165","article-title":"Adenovirus serotype 5 fiber shaft influences in\u00a0vivo gene transfer in mice","volume":"14","author":"Smith","year":"2003","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ejmech.2019.111840_bib26","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0092-8674(93)90231-E","article-title":"Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment","volume":"73","author":"Wickham","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2019.111840_bib27","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1128\/JVI.79.4.1992-2000.2005","article-title":"Adenovirus protein VI mediates membrane disruption following capsid disassembly","volume":"79","author":"Wiethoff","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2019.111840_bib28","doi-asserted-by":"crossref","first-page":"6492","DOI":"10.1128\/JVI.00557-08","article-title":"Neutralizing antibody blocks adenovirus infection by arresting microtubule-dependent cytoplasmic transport","volume":"82","author":"Smith","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2019.111840_bib29","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.chom.2011.08.010","article-title":"Kinesin-1-mediated capsid disassembly and disruption of the nuclear pore complex promote virus infection","volume":"10","author":"Strunze","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ejmech.2019.111840_bib30","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1242\/jcs.203794","article-title":"The nuclear export factor CRM1 controls juxta-nuclear microtubule-dependent virus transport","volume":"130","author":"Wang","year":"2017","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.ejmech.2019.111840_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002549","article-title":"Transcriptional activation of the adenoviral genome is mediated by capsid protein VI","volume":"8","author":"Schreiner","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2019.111840_bib32","series-title":"Adenovirus Gene Expression and Replication: a Historical Review, DNA Tumor Viruses: Control of Gene Expression and Replication","first-page":"37","author":"Pettersson","year":"1986"},{"key":"10.1016\/j.ejmech.2019.111840_bib33","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/0042-6822(72)90144-4","article-title":"Effect of -amanitin on adenovirus 5 multiplication","volume":"48","author":"Chardonnet","year":"1972","journal-title":"Virology"},{"key":"10.1016\/j.ejmech.2019.111840_bib34","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/newbio233247a0","article-title":"Inhibition by alpha-amanitin of adenovirus 12 replication in human embryo kidney cells and of adenovirus transformation of hamster cells","volume":"233","author":"Ledinko","year":"1971","journal-title":"Nat. New Biol."},{"key":"10.1016\/j.ejmech.2019.111840_bib35","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1002\/j.1460-2075.1984.tb02270.x","article-title":"Trans activation of transcription by herpes virus products: requirement for two HSV-1 immediate-early polypeptides for maximum activity","volume":"3","author":"Everett","year":"1984","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2019.111840_bib36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzym. Regul."},{"key":"10.1016\/j.ejmech.2019.111840_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173303","article-title":"Investigating antimalarial drug interactions of emetine dihydrochloride hydrate using CalcuSyn-based interactivity calculations","volume":"12","author":"Matthews","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2019.111840_bib38","doi-asserted-by":"crossref","first-page":"5476","DOI":"10.1182\/blood-2010-04-259291","article-title":"How I treat adenovirus in hematopoietic stem cell transplant recipients","volume":"116","author":"Lindemans","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2019.111840_bib39","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijpharm.2005.03.022","article-title":"Development and application of high throughput plasma stability assay for drug discovery","volume":"297","author":"Di","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejmech.2019.111840_bib40","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrd1156","article-title":"Drug research: myths, hype and reality","volume":"2","author":"Kubinyi","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2019.111840_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2019.111840_bib42","first-page":"103","article-title":"Design, synthesis, and biological evaluation of new N4-Substituted 2\u2019-deoxy-2\u2019-fluoro-4\u2019-azido cytidine derivatives as potent anti-HBV agents","volume":"101","author":"Lv","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111840_bib43","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/cmdc.201600182","article-title":"A\u00a0BOILED-egg to predict gastrointestinal absorption and brain penetration of small molecules","volume":"11","author":"Daina","year":"2016","journal-title":"ChemMedChem"},{"issue":"1","key":"10.1016\/j.ejmech.2019.111840_bib44","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejmech.2012.12.046","article-title":"Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents","volume":"62","author":"Duan","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111840_bib45","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1128\/JVI.02471-09","article-title":"Direct evidence from single-cell analysis that human {alpha}-defensins block adenovirus uncoating to neutralize infection","volume":"84","author":"Nguyen","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2019.111840_bib46","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/sj.mt.6300048","article-title":"Enhancement of gene transfer to human myeloid cells by adenovirus-fiber complexes","volume":"15","author":"Nepomuceno","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejmech.2019.111840_bib47","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0166-3542(02)00077-3","article-title":"Antiherpes simplex virus type 2 activity of casuarinin from the bark of Terminalia arjuna Linn","volume":"55","author":"Cheng","year":"2002","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2019.111840_bib48","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ejmech.2019.111840_bib49","first-page":"493","article-title":"Simple method of estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Hyg."},{"key":"10.1016\/j.ejmech.2019.111840_bib50","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.virol.2003.11.028","article-title":"Mode of transgene expression after fusion to early or late viral genes of a conditionally replicating adenovirus via an optimized internal ribosome entry site in\u00a0vitro and in\u00a0vivo","volume":"320","author":"Rivera","year":"2004","journal-title":"Virology"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419309924?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419309924?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:03:20Z","timestamp":1759327400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419309924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":54,"alternative-id":["S0223523419309924"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.111840","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimization of piperazine-derived ureas privileged structures for effective antiadenovirus agents","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.111840","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111840"}}